Alternative agents for anti-inflammatory treatment of asthma

    loading  Checking for direct PDF access through Ovid

Abstract

Recent guidelines for the management of asthma have emphasized the role of inflammation in persistent asthma. Medications with anti-inflammatory properties are recommended as the primary long-term-control medications. Of the available choices of long-term-control medications, inhaled corticosteroids are the preferred medication. A literature review of the available studies supports this recommendation of inhaled corticosteroids as the preferred agents for long-term control. Other long-term-control medications-specifically nedocromil, theophylline, and leukotriene modifiers, but not cromolyn-can supplement the beneficial effect of inhaled corticosteroids on pulmonary function and symptom control. Long-acting β2-adrenergic agonists can also provide an additive clinical benefit to inhaled corticosteroids on symptom control and pulmonary function, but they do not provide additional anti-inflammatory effect. Extended long-term studies of each of the long-term-control medications with anti-inflammatory actions are needed to assess their specific effect on airway remodeling and on the natural history of asthma.

Related Topics

    loading  Loading Related Articles